Abstract
Ivacaftor is currently used for the treatment of cystic fibrosis as both monotherapy (Kalydeco; Vertex Pharmaceuticals, Boston, MA) and combination th......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
